IIT Study of M1-c6v1 Combined With SHR-1210 and Apatinib in Patients With HCC

Clinical trial NCT04665362 · UNKNOWN

Trial details

NCT number: NCT04665362
Sponsor: Liang Peng
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced/Metastatic Hepatocellular Carcinoma

Start date: 2021-01-25
Primary completion: 2022-06-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.